These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21786109)

  • 21. [Preliminary results of the assessment of intensity modulated radiotherapy (IMRT) for prostatic and head and neck tumors (STIC 2001)].
    Marchal C; Lapeyre M; Beckendorf V; Aletti P; Haslé E; Dubois JB; Maingon P; Bensadoun RJ; Le Prise E; Lartigau E; Carrie C; Dubray B; Marchesi V; Ailleres N; Naudy S; Marcie S; Manens JP; Mazurier J; Ginestet C; Chauvin F; Pommier P; Gerard JP; Carrere MO
    Cancer Radiother; 2004 Nov; 8 Suppl 1():S121-7. PubMed ID: 15679257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inter-observer variability of clinical target volume delineation in definitive radiotherapy of neck lymph node metastases from unknown primary. A cooperative study of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) Head and Neck Group.
    Trignani M; Argenone A; Di Biase S; Musio D; Merlotti A; Ursino S; Orlandi E; Genovesi D; Bacigalupo A
    Radiol Med; 2019 Jul; 124(7):682-692. PubMed ID: 30852793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intensity-modulated radiotherapy: current status and issues of interest.
    Intensity Modulated Radiation Therapy Collaborative Working Group
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):880-914. PubMed ID: 11704310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improving dose homogeneity in routine head and neck radiotherapy with custom 3-D compensation.
    Harari PM; Sharda NN; Brock LK; Paliwal BR
    Radiother Oncol; 1998 Oct; 49(1):67-71. PubMed ID: 9886700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concepts and terms for dose/volume parameters in carbon-ion radiotherapy: Conclusions of the ULICE taskforce.
    Vogin G; Wambersie A; Pötter R; Beuve M; Combs SE; Magrin G; Mayer R; Mock U; Sarrut D; Schreiner T; Fossati P; Balosso J
    Cancer Radiother; 2018 Dec; 22(8):802-809. PubMed ID: 30327228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific recommendations for accurate and direct use of PET-CT in PET guided radiotherapy for head and neck sites.
    Thomas CM; Pike LC; Hartill CE; Baker S; Woods E; Convery DJ; Greener AG
    Med Phys; 2014 Apr; 41(4):041710. PubMed ID: 24694130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Image Guided Radiation Therapy (IGRT) Practice Patterns and IGRT's Impact on Workflow and Treatment Planning: Results From a National Survey of American Society for Radiation Oncology Members.
    Nabavizadeh N; Elliott DA; Chen Y; Kusano AS; Mitin T; Thomas CR; Holland JM
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):850-7. PubMed ID: 26972658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multicriteria optimization enables less experienced planners to efficiently produce high quality treatment plans in head and neck cancer radiotherapy.
    Kierkels RG; Visser R; Bijl HP; Langendijk JA; van 't Veld AA; Steenbakkers RJ; Korevaar EW
    Radiat Oncol; 2015 Apr; 10():87. PubMed ID: 25885444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the trade-offs encountered in planning and treating locally advanced head and neck cancer: intensity-modulated radiation therapy vs dual-arc volumetric-modulated arc therapy.
    Oliver M; McConnell D; Romani M; McAllister A; Pearce A; Andronowski A; Wang X; Leszczynski K
    Br J Radiol; 2012 Dec; 85(1020):1539-45. PubMed ID: 22806619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperfractionated accelerated radiotherapy with concomitant integrated boost of 70-75 Gy in 5 weeks for advanced head and neck cancer. A phase I dose escalation study.
    Cvek J; Kubes J; Skacelikova E; Otahal B; Kominek P; Halamka M; Feltl D
    Strahlenther Onkol; 2012 Aug; 188(8):666-70. PubMed ID: 22648405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Managing patient flows in radiation oncology during the COVID-19 pandemic : Reworking existing treatment designs to prevent infections at a German hot spot area University Hospital.
    Akuamoa-Boateng D; Wegen S; Ferdinandus J; Marksteder R; Baues C; Marnitz S
    Strahlenther Onkol; 2020 Dec; 196(12):1080-1085. PubMed ID: 33123776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intensity-modulated radiation therapy for head-and-neck cancer: the UCSF experience focusing on target volume delineation.
    Lee N; Xia P; Fischbein NJ; Akazawa P; Akazawa C; Quivey JM
    Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):49-60. PubMed ID: 12909215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient positioning in head and neck cancer : Setup variations and safety margins in helical tomotherapy.
    Leitzen C; Wilhelm-Buchstab T; Müdder T; Heimann M; Koch D; Schmeel C; Simon B; Stumpf S; Vornholt S; Garbe S; Röhner F; Schoroth F; Schild HH; Schüller H
    Strahlenther Onkol; 2018 May; 194(5):386-391. PubMed ID: 29372290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiation therapy for benign diseases: patterns of care study in Germany.
    Seegenschmiedt MH; Katalinic A; Makoski H; Haase W; Gademann G; Hassenstein E
    Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):195-202. PubMed ID: 10758324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Daily ultrasound-based image-guided targeting for radiotherapy of upper abdominal malignancies.
    Fuss M; Salter BJ; Cavanaugh SX; Fuss C; Sadeghi A; Fuller CD; Ameduri A; Hevezi JM; Herman TS; Thomas CR
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1245-56. PubMed ID: 15234062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Helical tomotherapy. Experiences of the first 150 patients in Heidelberg.
    Sterzing F; Schubert K; Sroka-Perez G; Kalz J; Debus J; Herfarth K
    Strahlenther Onkol; 2008 Jan; 184(1):8-14. PubMed ID: 18188517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The place of conformal radiotherapy in routine practice: national survey of SFRO members].
    Lagrange JL; Lipinski F
    Cancer Radiother; 2001 Nov; 5 Suppl 1():44s-48s. PubMed ID: 11797284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FDG-PET/CT-guided intensity modulated head and neck radiotherapy: a pilot investigation.
    Schwartz DL; Ford EC; Rajendran J; Yueh B; Coltrera MD; Virgin J; Anzai Y; Haynor D; Lewellen B; Mattes D; Kinahan P; Meyer J; Phillips M; Leblanc M; Krohn K; Eary J; Laramore GE
    Head Neck; 2005 Jun; 27(6):478-87. PubMed ID: 15772953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The development of quality assurance programs for radiotherapy within the German Hodgkin Study Group (GHSG). Introduction, continuing work, and results of the radiotherapy reference panel.
    Müller RP; Eich HT
    Strahlenther Onkol; 2005 Sep; 181(9):557-66. PubMed ID: 16170482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of RTOG 0614 and RTOG 0933 trials in routine clinical practice: The US Survey of Utilization of Memantine and IMRT planning for hippocampus sparing in patients receiving whole brain radiotherapy for brain metastases.
    Slade AN; Stanic S
    Contemp Clin Trials; 2016 Mar; 47():74-7. PubMed ID: 26718093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.